TriLink BioTechnologies, part of Maravai LifeSciences, is a CDMO helping life science leaders and innovators overcome challenges in the synthesis and scale-up of nucleic acids, NTPs and mRNA capping analogs with scale-up expertise and unique mRNA...
When considering a CRM197 supplier, product consistency, availability, and quality should be the key drivers in sourcing. Produced using the Pelican Expression Technology™ platform, based on Pseudomonas fluorescens, the Pelican CRM197 carrier...
Codiak BioSciences (Nasdaq: CDAK) is a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high ...
Flourish Research represents one of the industry’s most progressive and diversified trial solutions with robust capabilities across core therapeutic areas of cardiology/metabolic disorders, CNS disorders, and vaccines.
Johnson & Johnson Innovation – JLABS (‘JLABS’) is the premier life science incubator aimed at empowering and enabling innovators across a broad healthcare spectrum including pharmaceutical, medical device, consumer and health tech sectors to...
Precision NanoSystems, now part of the Danaher Life Sciences platform, is a global leader in ushering in the next wave of genomic medicines for infectious diseases, cancer, and rare diseases. Collaborating with the world’s leading drug developers to ...
Vaxess is a clinical-stage company bringing healthcare out of the clinic and into patients’ lives with the shelf-stable, self-applied MIMIX patch platform. The company has a pipeline of vaccines and biologics under development, including the first...
"We are Vida Clinical Studies, we started out in the heart of the medical community in Dearborn, Michigan and now have developed a network of the sites throughout the U.S and the Middle East.. Our sites and staff come from a diverse community...
Based at Boston Children’s Hospital, the Precision Vaccines Program (PVP) is an academic research program discovering and developing the next generation of vaccines tailored to vulnerable populations. The PVP team conducts basic and translational...
Cedar Health Research is a multi-therapeutic clinical research site and patient network that utilizes Aspen Insights’ technology, Aspen Forge, to integrate with provider EMRs for streamlined patient access supported by a centralized recruitment...
The Frederick National Laboratory is a Federally Funded Research and Development Center (FFRDC) sponsored by the National Cancer Institute (NCI) and currently operated by Leidos Biomedical Research, Inc. The laboratory addresses some of the most...
International Vaccine Institute (IVI)The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and...
Invest Liverpool City Region is the inward investment brand used by Growth Platform – Liverpool City Region Growth Company to promote opportunities for national and international businesses to locate, invest and expand in the City Region.Liverpool...
The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) and its Medical Countermeasures Systems group seeks innovative, safe and effective medical solutions to counter exposure/potential exposure to ...
For more than 40 years, Onset has been a world leader in temperature data logging and monitoring solutions. Onset’s InTemp product line was developed to meet the unique requirements of pharmaceutical cold chain monitoring applications and the CDC’s...
SeriTech's products use a unique microneedling technology for affordable vaccination to the world.
Select Greater Philadelphia is committed to helping companies achieve their vision by facilitating growth in Greater Philadelphia, a region that is connected, collaborative, and accessible to the world. We welcome prospective businesses, talent, and ...
We're developing first-in-class inhalable and infection-activated RNA therapeutics from COVID-19 and influenza to RSV. Our lead candidate provides single-administration protection against any coronavirus.
USSF located in Allentown, Pennsylvania, Dr. Flanigan is leading his team to bring QYNDR, an oral mucosal vaccine delivery platform currently targeting the COVID-19 vaccine, to market – one that will be easier to use, longer lasting and with fewer...